Location History:
- Germantown, TN (US) (2008 - 2013)
- Kent Vale, SG (2017)
- Singapore, SG (2016 - 2024)
Company Filing History:
27 out of 806 
22 out of 260 
2 out of 7 Years Active: 2008-2025
Title: Dario Campana: A Pioneer in Immunotherapy Innovations
Introduction: Dario Campana, located in Singapore, is a prominent inventor renowned for his remarkable contributions to the field of immunotherapy, particularly in developing novel therapies for T-cell malignancies. With an impressive portfolio of 30 patents, Campana is a leading figure in advancing cancer treatment through innovative research.
Latest Patents: Among his latest patents, two notable inventions stand out. The first, titled "Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies," focuses on engineered immune cells that include an anti-CD2 protein expression blocker (PEBL) and an anti-CD2 chimeric antigen receptor (CAR). This invention is significant as it describes methods for utilizing such engineered cells in cancer therapies, particularly through the blockade of CD2 surface expression.
The second patent, "Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies," presents compositions that involve an anti-CD7 chimeric activating receptor (CAR) and an anti-CD7 protein expression blocker. This invention also provides methods for employing these compositions in cancer therapy, further showcasing Campana's dedication to improving cancer treatment options.
Career Highlights: Dario Campana has made significant strides in his career, working with esteemed institutions such as St. Jude Children's Research Hospital and the National University of Singapore. His work in these prominent research settings has not only advanced his expertise but also played a critical role in the evolution of immunotherapy strategies.
Collaborations: Campana has collaborated with various talented individuals in the field, including notable coworkers Chihaya Imai and Yu-Hsiang Chang. These partnerships have facilitated the exchange of ideas and research techniques, reinforcing the innovative outcomes of his projects.
Conclusion: Dario Campana exemplifies the spirit of innovation and dedication to medical research. With a focus on immunotherapy for T-cell malignancies and a robust patent portfolio, his contributions have the potential to make a significant impact in cancer treatment. His ongoing research and collaborations continue to pave the way for new breakthroughs in the battle against cancer.